Home » Idenix Pharmaceuticals Highlights Progress in Three HCV Programs
Idenix Pharmaceuticals Highlights Progress in Three HCV Programs
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in
the discovery and development of drugs for the treatment of human viral diseases, Monday announced significant progress in three HCV programs.
Fox Business
Fox Business
Upcoming Events
-
07May
-
14May
-
30May